Evidence map›Paper›PMID 33330224›Full record

ReviewClinics in shoulder and elbow2019

Current Trends for Treating Lateral Epicondylitis.

Gyeong Min Kim, Seung Jin Yoo, Sungwook Choi, Yong-Geun Park

Registry-linked trialOpen access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinics in shoulder and elbow, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06040203 (Leukocyte-rich PRP or Leukocyte-free PRP vs Placebo in the Treatment of Epicondylitis), which is not on this map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06040203 narecruitingnot on this mapstarted 2023, after this paper: background citation

Leukocyte-rich PRP or Leukocyte-free PRP vs Placebo in the Treatment of Epicondylitis: a Randomized Controlled Clinical Trial

TypeinterventionalSponsorIstituto Ortopedico RizzoliRan2023 to 2027Enrolled240ConditionsTennis ElbowArmsInjection of autologous leukocyte rich platelet rich plasma (LR-PRP), Injection of autologous leukocyte poor platelet rich plasma (LP-PRP), Placebo (saline solution)
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Comparison of extracorporeal shockwave therapy, ultrasound therapy, and corticosteroid injections for treatment of lateral epicondylitis: an umbrella review of meta-analyses.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2025
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. TikTok content as a source of health education regarding epicondylitis: a content analysis.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gyeong Min KimDepartment of Orthopedic Surgery, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea.
Seung Jin YooDepartment of Orthopedic Surgery, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea.
Sungwook ChoiDepartment of Orthopedic Surgery, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea.
Yong-Geun ParkDepartment of Orthopedic Surgery, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea.ORCID 0000-0002-9156-1203
Jeju National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lateral epicondylitis, also known as 'tennis elbow', is a degenerative rather than inflammatory tendinopathy, causing chronic recalcitrant pain in elbow joints. Although most patients with lateral epicondylitis resolve spontaneously or with standard conservative management, few refractory lateral epicondylitis are candidates for alternative non-operative and operative modalities. Other than standard conservative treatments including rest, analgesics, non-steroidal anti-inflammatory medications, orthosis and physical therapies, nonoperative treatments encompass interventional therapies include different types of injections, such as corticosteroid, lidocaine, autologous blood, platelet-rich plasma, and botulinum toxin, which are available for both short-term and long-term outcomes in pain resolution and functional improvement. In addition, newly emerging biologic enhancement products such as bone marrow aspirate concentrate and autologous tenocyte injectates are also under clinical use and investigations. Despite all non-operative therapeutic trials, persistent debilitating pain in patients with lateral epicondylitis for more than 6 months are candidates for surgical treatment, which include open, percutaneous, and arthroscopic approaches. This review addresses the current updates on emerging non-operative injection therapies as well as arthroscopic intervention in lateral epicondylitis.

Indexed as

ArthroscopyInjectionsPlatelet-rich plasmaTennis elbow

Identifiers

PMID33330224
PMCPMC7714311
OpenAlexW2990687938

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.